Group 1 - China Rejuvenation Medicine (08158) announced the acquisition of 55% equity in Kangmeizhan Biotechnology Development Co., Ltd. for HKD 5.5 billion from China Star Entertainment (BVI) Limited [1] - Following the acquisition, China Rejuvenation and China Star will hold 55% and 45% stakes in Kangmeizhan, respectively [1] - A shareholders' agreement was established to regulate the rights and obligations of China Rejuvenation, China Star, and Kangmeizhan upon completion of the transaction [1] Group 2 - The strategic cooperation aims to leverage the strengths and resources of each party, enhancing competitiveness in the Macau market [2] - Kangmeizhan will benefit from the industry resources and experience of the group in aesthetic medical and beauty services, achieving synergistic effects [2] - This collaboration marks a significant milestone for the group in expanding into the new market of Macau, creating new market opportunities and business value for each company [2]

Group 1 - China Regen Med (08158) announced a purchase agreement on January 2, 2026, where its wholly-owned subsidiary, China Regen (Hong Kong) Investment Co., will acquire 55% of the shares in Kangmeizhan Biotechnology Development Co., Ltd. for HKD 5,500 [1] - Following the acquisition, China Regen (Hong Kong) and China Star will hold 55% and 45% of Kangmeizhan's shares, respectively, with a shareholder agreement established to regulate their rights and obligations [1] - Kangmeizhan will operate as an investment holding company, focusing on investments in the Macau Special Administrative Region and collaborating with other strategic investors to manage clinic operations [1] Group 2 - The strategic cooperation aims to leverage the respective professional capabilities and resource advantages of the parties involved, enhancing the group's competitiveness in Macau through China Star's resources and business relationships [2] - Kangmeizhan will benefit from the group's industry resources and extensive experience in aesthetic medical and beauty services, achieving synergistic effects [2] - This strategic cooperation marks a significant milestone for the group in expanding into the new market of Macau, creating new market opportunities and commercial value for each company involved [2]